SCOPIA CAPITAL MANAGEMENT LP - Q2 2017 holdings

$4.85 Billion is the total value of SCOPIA CAPITAL MANAGEMENT LP's 35 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 40.6% .

 Value Shares↓ Weighting
FCEA SellFOREST CITY RLTY TR INC$570,067,000
+10.6%
23,585,735
-0.4%
11.76%
+23.5%
SPR BuySPIRIT AEROSYSTEMS HLDGS INC$432,272,000
+13.0%
7,460,682
+13.0%
8.92%
+26.2%
NFLX SellNETFLIX INC$380,168,000
+0.6%
2,544,460
-0.4%
7.84%
+12.4%
ITRI  ITRON INC$308,831,000
+11.6%
4,558,3870.0%6.37%
+24.7%
BIDU SellBAIDU INCspon adr rep a$291,871,000
-4.8%
1,631,838
-8.1%
6.02%
+6.4%
JCI SellJOHNSON CTLS INTL PLC$255,292,000
-19.8%
5,887,736
-22.1%
5.27%
-10.4%
GWPH BuyGW PHARMACEUTICALS PLCads$250,097,000
+4.0%
2,494,738
+25.5%
5.16%
+16.2%
JD SellJD COM INCspon adr cl a$244,171,000
-26.4%
6,225,674
-41.6%
5.04%
-17.8%
HZNP BuyHORIZON PHARMA PLC$181,708,000
+26.9%
15,308,143
+58.0%
3.75%
+41.8%
SRC NewSPIRIT RLTY CAP INC NEW$157,844,00021,301,460
+100.0%
3.26%
TMH  TEAM HEALTH HOLDINGS INC$145,231,0000.0%3,338,6490.0%3.00%
+11.7%
ACOR BuyACORDA THERAPEUTICS INC$142,311,000
+21.7%
7,223,906
+29.7%
2.94%
+35.9%
CNMD  CONMED CORP$141,310,000
+14.7%
2,774,0450.0%2.92%
+28.1%
 NEURODERM LTD$131,062,000
+12.6%
4,383,3580.0%2.70%
+25.8%
FNF SellFIDELITY NATIONAL FINANCIAL$129,882,000
+3.5%
2,897,201
-10.1%
2.68%
+15.6%
ATUS NewALTICE USA INCcl a$117,241,0003,629,740
+100.0%
2.42%
RTRX BuyRETROPHIN INC$115,819,000
+6.6%
5,973,111
+1.5%
2.39%
+19.1%
CNDT BuyCONDUENT INC$111,249,000
+123.9%
6,979,221
+135.7%
2.30%
+150.0%
VST NewVISTRA ENERGY CORP$106,180,0006,324,010
+100.0%
2.19%
AR BuyANTERO RES CORP$100,356,000
+29.7%
4,643,955
+36.9%
2.07%
+44.9%
CNX BuyCONSOL ENERGY INC$95,017,000
+3.3%
6,359,895
+16.0%
1.96%
+15.4%
UTHR SellUNITED THERAPEUTICS CORP DEL$91,460,000
-71.5%
705,003
-70.3%
1.89%
-68.2%
LGND SellLIGAND PHARMACEUTICALS INC$88,448,000
-28.2%
728,563
-37.4%
1.82%
-19.8%
TRGP BuyTARGA RES CORP$87,263,000
-0.8%
1,930,592
+31.5%
1.80%
+10.8%
BIDU NewBAIDU INCcall$71,544,000400,000
+100.0%
1.48%
AAAP SellADVANCED ACCELERATOR APPLICsponsored ads$41,779,000
-14.9%
1,070,163
-13.1%
0.86%
-5.0%
AMGP NewANTERO MIDSTREAM GP LP$20,552,000935,053
+100.0%
0.42%
ETM NewENTERCOM COMMUNICATIONS CORPcl a$12,916,0001,247,952
+100.0%
0.27%
OMI NewOWENS & MINOR INC NEW$12,487,000387,901
+100.0%
0.26%
INTEQ SellINTELSAT S A$4,551,000
-45.5%
1,487,257
-26.1%
0.09%
-39.0%
FOSL  FOSSIL GROUP INC$4,098,000
-40.7%
395,9250.0%0.08%
-33.6%
MRSN NewMERSANA THERAPEUTICS INC$2,845,000203,626
+100.0%
0.06%
MNKD  MANNKIND CORP$1,386,000
-4.7%
982,9300.0%0.03%
+7.4%
PSEC  PROSPECT CAPITAL CORPORATION$846,000
-10.2%
104,1940.0%0.02%0.0%
AMSC  AMERICAN SUPERCONDUCTOR CORP$91,000
-32.6%
19,6100.0%0.00%0.0%
DY ExitDYCOM INDS INC$0-591,701
-100.0%
-1.02%
SWX ExitSOUTHWEST GAS HOLDINGS INC$0-997,996
-100.0%
-1.53%
WMB ExitWILLIAMS COS INC DEL$0-4,763,883
-100.0%
-2.60%
IWM ExitISHARES TRput$0-2,410,600
-100.0%
-6.12%
SPY ExitSPDR S&P 500 ETF TRput$0-1,516,800
-100.0%
-6.60%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SPIRIT AEROSYSTEMS HLDGS INC39Q4 202228.3%
SPDR S&P 500 ETF TR31Q3 202316.9%
ISHARES TR28Q3 202310.9%
MANNKIND CORP24Q3 20230.5%
BAIDU INC21Q2 20188.6%
ITRON INC21Q3 202012.1%
RETROPHIN INC20Q3 20204.5%
HARMONIC INC19Q3 202310.5%
JOHNSON CTLS INTL PLC17Q3 20209.6%
ACORDA THERAPEUTICS INC17Q3 20194.0%

View SCOPIA CAPITAL MANAGEMENT LP's complete holdings history.

Latest significant ownerships (13-D/G)
SCOPIA CAPITAL MANAGEMENT LP Q2 2017 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
VERRA MOBILITY CorpOctober 28, 20226,710,0744.4%
Spirit AeroSystems Holdings, Inc.February 14, 20222,084,2122.0%
Retrophin, Inc.February 14, 20202,011,6974.7%
Horizon Therapeutics Public Ltd CoJanuary 10, 20202,527,4561.4%
ZOGENIX, INC.January 10, 2020919,4842.1%
ITRON, INC.January 07, 20201,808,0594.6%
ACORDA THERAPEUTICS INCSold outNovember 12, 201900.0%
LA JOLLA PHARMACEUTICAL COApril 10, 2019480,0001.8%
Prothena Corp plcMarch 11, 20191,883,8164.7%
GW PHARMACEUTICALS PLCFebruary 14, 20191,345,1984.6%

View SCOPIA CAPITAL MANAGEMENT LP's complete significant-ownership history.

Latest filings
TypeFiled
SC 13D2024-04-26
13F-HR2024-02-14
SC 13G2024-02-14
SC 13D/A2024-01-22
13F-HR/A2023-11-14
13F-HR2023-11-14
SC 13D2023-09-21
13F-HR2023-08-14
13F-HR2023-05-15
SC 13D/A2023-04-12

View SCOPIA CAPITAL MANAGEMENT LP's complete filings history.

Compare quarters

Export SCOPIA CAPITAL MANAGEMENT LP's holdings